10:31 ETPost-Bariatric Hypoglycemia Market to Register Stunning Growth at a 16.4% CAGR Through 2036 Owing to the Emergence of Novel Drug Classes Such as GLP-1 Receptor Antagonists, SGLT1 Inhibitors, CRH Inhibitors, and SSTR5 Agonists | DelveInsight
Kissei Pharmaceutical's (TSE:4547) Solid Earnings May Rest On Weak Foundations
Amgen Japanese Partner Urges Caution On Tavneos Use
Dow Jones Top Company Headlines at 5 PM ET: SpaceX Is Aiming to Go Public on June 12 in What Stands to Be Biggest IPO Ever | Anthropic ...
Kissei Pharmaceutical (TSE:4547) One Off Gain Lifts Margin And Tests Bullish Earnings Narrative
Kissei Pharmaceutical Swings to Operating Loss but Lifts Payouts and Eyes Profit Recovery